7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-06-30 2013-05-07 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2009-12-31 2009-09-30 2009-06-30 2008-12-31 2008-06-30 2008-05-07 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 
      
                                                                               
      revenue
    27,767,000 542,709,000   3,551,000 16,097,000 15,825,000 146,267,000 62,546,000 31,575,000 32,412,000 151,805,000 27,439,000 38,283,000 45,891,000 32,811,000 21,303,000 7,632,855 27,375,778 23,528,853 29,454,579 43,292,770 42,696,636 48,148,275 34,657,896 11,255,000 9,342,498 8,985,930 4,365,496 8,713,786 39,583 43,750 43,750 31,250 123,750 43,750 170,750 43,750 43,750 43,750 43,750 43,750 43,750 43,750 159,016 43,750  43,750 159,016 4,035,709 47,917 31,250 23,958 3,695,820   4,994,969 7,688,333 133,990 148,068        157,498.5 622,599 -3,697 11,092 39,229 246,229 57,500 252,500 
      yoy
    681.95% 3271.49%   -94.32% -49.02% -51.18% -3.65% 127.95% -17.52% -29.37% 362.66% 28.80% 401.56% 67.63% 39.45% -27.68% -82.37% -35.88% -51.13% -15.01% 284.65% 357.02% 435.82% 693.91% 29.16% 23502.30% 20439.27% 9878.28% 27784.12% -68.01% 0.00% -74.38% -28.57% 182.86% 0.00% 290.29% 0.00% 0.00% 0.00% -72.49% 0.00%  0.00% 0.00% -98.92%  40.00% 563.73% 9.20%   -99.52% -51.93%              301.48% 152.85% -106.43% -95.61%     
      qoq
    -94.88%    -77.94% 1.72% -89.18% 133.86% 98.09% -2.58% -78.65% 453.25% -28.33% -16.58% 39.86% 54.02% 179.10% -72.12% 16.35% -20.12% -31.96% 1.40% -11.32% 38.92% 207.93% 20.47% 3.97% 105.84% -49.90% 21913.96% -9.52% 0.00% 40.00% -74.75% 182.86% -74.38% 290.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -72.49% 263.47%   -72.49% -96.06% 8322.29% 53.33% 30.44% -99.35%    -35.03% 5637.99% -9.51%         -74.70% -16940.65% -133.33% -71.72% -84.07% 328.22% -77.23%  
      operating expenses:
                                                                               
      research and development
    162,368,000 133,102,000 152,431,000 101,122,000 116,491,000 99,855,000 94,757,000 74,881,000 83,695,000 83,377,000 72,180,000 75,985,000 65,765,000 65,766,000 59,325,000 44,697,000 36,555,000 43,484,893 32,573,134 29,443,335 23,373,616 23,386,305 19,291,710 20,798,628 17,572,043 15,993,880 11,136,741 11,438,216 9,527,051 8,280,406 9,423,195 10,020,826 10,338,833 11,671,598 7,490,400 11,640,794 17,744,312 10,389,436 6,392,200 5,216,446 3,133,014 8,418,311 1,756,527 2,125,019 1,576,666 1,756,527  2,125,019 1,576,666 39,271,746 1,219,236 1,358,691 1,140,904 37,660,599 365,618 140,658 3,509,458 53,874,993 227,804 277,788 45,990,806 2,519,325 3,923,304 3,349,423  1,690,037 1,664,689 20,001,639 8,563,401 4,465,475  984,976.5 1,081,332 1,136,181  
      general and administrative
    30,949,000 28,405,000 23,710,000 25,069,000 23,605,000 24,572,000 23,771,000 23,221,000 20,985,000                                                                   
      total operating expenses
    193,317,000 161,507,000 176,141,000 126,191,000 140,096,000 124,427,000 118,528,000 98,102,000 104,680,000 115,405,000 105,321,000 110,252,000 90,760,000 103,166,000 77,759,000 61,043,000 45,357,000 57,751,947 43,321,640 45,769,108 34,308,173 33,654,721 24,100,887 26,137,583 23,711,752 22,424,109 15,056,662 15,115,572 19,267,383 18,963,999 19,381,070 21,308,605 19,385,020 21,826,365 16,117,456 29,676,493 25,286,026 25,273,582 12,743,850 11,256,248 7,053,132 22,398,058 6,433,615 5,434,038 4,969,037 6,433,615  5,434,038 4,969,037 105,540,989 6,850,853 4,900,007 4,062,997 92,905,072 1,770,165 1,811,618 6,004,286 128,867,102 2,298,099 2,308,286 107,530,443 4,956,951 9,376,404 9,971,212  7,407,638 6,960,778 46,087,190 13,672,290 8,432,841 4,484,732 8,798,971 4,729,227 4,002,650 4,305,232 
      operating income
    -165,550,000 381,202,000 -176,141,000 -126,191,000 -136,545,000 -108,330,000 -102,703,000 48,165,000 -42,134,000 -83,830,000 -72,909,000 41,553,000 -63,321,000 -64,883,000 -31,868,000 -28,232,000 -24,054,000 -50,119,092 -15,945,862 -22,240,255 -4,853,594 9,638,049 18,595,749 22,010,692 10,946,144 -11,169,109 -5,714,164 -6,129,642 -14,901,887 -10,250,213 -19,341,487 -21,264,855 -19,341,270 -21,795,115 -15,993,706 -29,632,743 -25,115,276 -25,229,832 -12,700,100 -11,212,498 -7,009,382 -22,354,308 -6,389,865 -5,390,288 -4,810,021 -6,389,865  -5,390,288 -4,810,021 -101,505,280 -6,802,936 -4,868,757 -4,039,039 -89,209,252 -1,770,165 -1,811,618 -1,009,317 -121,178,769 -2,164,109 -2,160,218 -103,578,368 -2,323,760 -8,674,681 -9,896,582  -7,072,689 -6,885,123 -44,503,202 -13,397,292 -8,436,538 -4,473,640 -8,759,742 -4,482,998 -3,945,150 -4,052,732 
      yoy
    21.24% -451.89% 71.51% -362.00% 224.07% 29.23% 40.86% 15.91% -33.46% 29.20% 128.78% -247.18% 163.25% 29.46% 99.85% 26.94% 395.59% -620.01% -185.75% -201.04% -144.34% -186.29% -425.43% -459.09% -173.45% 8.96% -70.46% -71.17% -22.95% -52.97% 20.93% -28.24% -22.99% -13.61% 25.93% 164.28% 258.31% 12.86% 98.75% 108.01% 45.72% 249.84%  0.00% 0.00% -93.70%  10.71% 19.09% 13.78% 284.31% 168.75% 300.18% -26.38% -18.20% -16.14% -99.03% 5114.77% -75.05% -78.17%  -67.14% 25.99% -77.76%  -16.17% 53.90% 408.04% 198.85% 113.85% 10.39%     
      qoq
    -143.43% -316.42% 39.58% -7.58% 26.05% 5.48% -313.23% -214.31% -49.74% 14.98% -275.46% -165.62% -2.41% 103.60% 12.88% 17.37% -52.01% 214.31% -28.30% 358.22% -150.36% -48.17% -15.51% 101.08% -198.00% 95.46% -6.78% -58.87% 45.38% -47.00% -9.04% 9.95% -11.26% 36.27% -46.03% 17.99% -0.45% 98.66% 13.27% 59.96% -68.64% 249.84% 18.54% 12.06% -24.72%   12.06% -95.26% 1392.08% 39.73% 20.54% -95.47% 4939.60% -2.29% 79.49% -99.17% 5499.48% 0.18% -97.91% 4357.36% -73.21% -12.35%   2.72% -84.53% 232.18% 58.80% 88.58% -48.93% 95.40% 13.63% -2.65%  
      operating margin %
    -596.21% 70.24%   -3845.25% -672.98% -648.99% 32.93% -67.36% -265.49% -224.94% 27.37% -230.77% -169.48% -69.44% -86.04% -112.91% -656.62% -58.25% -94.52% -16.48% 22.26% 43.55% 45.71% 31.58% -99.24% -61.16% -68.21% -341.36% -117.63% -48863.12% -48605.38% -44208.62% -69744.37% -12924.21% -67731.98% -14708.80% -57668.19% -29028.80% -25628.57% -16021.44% -51095.56% -14605.41% -12320.66% -3024.87% -14605.41%  -12320.66% -3024.87% -2515.18% -14197.33% -15580.02% -16858.83% -2413.79%   -20.21% -1576.14% -1615.13% -1458.94%        -28256.27% -2151.83% 228199.57% -40332.13% -22329.76% -1820.66% -6861.13% -1605.04% 
      other income:
                                                                               
      interest income
    11,019,000 9,615,000 6,498,000 6,250,000 2,802,000 3,885,000 4,172,000 4,560,000 -167,000 1,583,000 1,240,000 1,054,000 1,156,000 1,148,000 1,280,000 1,524,000 2,169,000 2,271,301 2,334,649 2,404,685 2,179,866 2,240,409 1,739,959 1,886,290 1,091,109 402,745 131,358 108,744 25,148 149,878 34,103 79,060 100,380 52,251 162,366 198,113 237,417 131,262 226,424 119,390 40,578 259,101 -48,252 -27,567 7,416 -48,252  -27,567 7,416 2,723,118 14,436 5,015 7,875 2,643,663 20,531 35,037 3,338 2,811,608 -12,877 -22,025 2,996,419 -78,526 13,535 115,158  232,879 315,373 1,420,461 238,277 328,098 313,217 271,697 223,443 181,310 176,516 
      interest expense
    -24,382,000 -21,639,000 -5,094,000 -7,244,000 -5,367,000 -5,262,000 -5,158,000 -5,057,000                                                                    
      other
    -176,000 438,000 760,000 189,000 421,000 717,000 306,000 8,000                                                                    
      total other income
    -13,539,000 -11,586,000 2,164,000 -805,000 -2,144,000 -660,000 -680,000 -489,000 340,000 1,673,000 863,000 2,813,000 449,000 1,511,000 1,944,000 1,414,000 3,322,000 1,688,777 2,334,649 2,404,685 2,179,866 2,240,409 1,739,959 1,886,290 1,091,109 410,238 194,423 87,085 2,815,779 -479,273 -79,256 448,995 76,856 -424,471 57,653 948,750 2,539,994 489,096 1,073,649 -2,770,202 -3,676,350 -70,924 212,237 -1,549,395 29,312 212,237  -1,549,395 29,312 7,200,278 -1,436,802 -714,875 1,352,461 6,343,376 -174,507 724,282 517,434 5,960,953 1,485,862 -70,444 5,634,752 -204,857 644,153 115,158  232,879 315,373 4,099,162 238,277 328,098 766,470 -19,781 508,850 838,564 915,779 
      income before income tax expense and noncontrolling interest
    -179,089,000 369,616,000    -108,990,000 -103,383,000 47,676,000 -41,794,000                                                                   
      income tax (benefit) expense
    -437,000    -3,313,000                                                                       
      net income including noncontrolling interest
    -178,652,000 367,863,000 -173,977,000 -126,996,000 -135,376,000 -111,015,000 -104,125,000 47,676,000 -41,811,000                                                                   
      net income attributable to noncontrolling interest, net of tax
    -3,411,000 -2,582,000 -3,184,000 -1,696,000 -2,512,000 -1,336,000 -1,179,000 -999,000 -486,000                                                                   
      net income attributable to arrowhead pharmaceuticals, inc.
    -175,241,000 370,445,000 -170,793,000 -125,300,000 -132,864,000 -109,679,000 -102,946,000 48,675,000 -41,325,000                                                                   
      net income per share
             -0.215 -0.68 0.42 -0.6 -0.61 -0.29 -0.26 -0.2 -0.48 -0.13 -0.2 -0.03 0.12 0.21 0.25 0.13 -0.12 -0.07 -0.08 -0.17 -0.15 -0.32 -0.35 -0.32 -0.34 -0.27 -0.51      -0.44 -0.23 -0.41  -0.23                 -0.19 -0.19  -0.15 -0.14 -0.16 -0.34 -0.18 -0.11 -0.26 -0.12 -0.1 -0.11 
      basic
    -1.26 2.78 -1.38 -1.02 -1.24 -1.02 -0.96 0.46 -0.39                                                                   
      diluted
    -1.26 2.75 -1.38 -1.02 -1.24 -1.02 -0.96 0.45 -0.39                                                                   
      weighted-average shares used for eps calculation
                                                                               
      basic
    139,039 133,363 124,199 123,285 107,415 106,750 107,004 106,757 106,039 105,426                                                                  
      diluted
    139,039 134,484 124,199 123,285 107,415 106,750 107,004 108,143 106,039 105,426                                                                  
      other comprehensive income, net of tax:
                                                                               
      unrealized gains on available-for-sale securities
    876 653                                                                          
      foreign currency translation adjustments
    91 -400 -141 -56 58 153 -79 -74 -122 -33 -39 -131 -40 -96 180 193,652 453,895 -433,564 196,074 -288,546 -31,172 -28,162 -22,180 -18,226 12,309 154,464 -192,608 51,618 -90,625 150,520 45,818 38,161 -1,982 -63,965  -70,478                                      
      comprehensive income
    -177,685 368,116  -126,836    47,602  -22,655.75 -72,079 44,367 -62,911 -63,505 -29,964 -26,914 -20,552 -48,239,063 -13,157,318 -20,269,134 -2,477,654 11,416,359 20,304,536 23,868,820 12,015,073                                                   
      income tax benefit
     1,753,000                                                                          
      income before income tax benefit and noncontrolling interest
      -173,977,000                                                                         
      other comprehensive loss, net of tax:
                                                                               
      change in unrealized losses on available-for-sale securities
      249 216 1,909                                                                       
      comprehensive loss
      -173,869  -133,409 -113,826 -104,204  -41,933                 -10,779,497 -5,507,432 -5,888,093 -12,278,716 -10,680,268 -19,511,368 -20,665,340 -19,218,596                                           
      income before income tax (benefit) expense and noncontrolling interest
       -126,996,000 -138,689,000                                                                       
      income tax expense
         2,025,000 742,000  17,000                                                                   
      other income
            507,000 90,000 -377,000 1,759,000 -707,000 363,000 664,000 -110,000 1,153,000           5,724 1,306,800       536,087 -53,184 -65,030 10,054 76,546 -5,331 823 259,221 -1,279,881 22,685 259,221  -1,279,881 22,685         88,963  220                
      operating expenses
                                                                               
      general and administrative expenses
             23,100,750 33,141,000 34,267,000 24,995,000 37,400,000 18,434,000 16,346,000 8,802,000 14,267,054 10,748,506 16,325,773 10,934,557 10,268,416 4,809,177 5,338,955 6,139,709 6,430,229 3,919,921 3,677,356 1,854,174 1,507,685 2,275,628 3,818,335 1,951,609 1,895,166 1,829,393 1,696,623 2,086,202 2,318,965 1,582,465 1,347,677 913,784 2,028,163 899,633 779,970 917,676 899,633  779,970 917,676 26,018,024 3,137,368 930,914 1,277,904 23,493,277 643,165 822,812 1,128,957 23,898,636 869,307 746,250 19,615,497 1,041,883 1,629,987 1,720,206  1,582,743 1,697,776 9,179,676 1,567,426 1,458,997  947,758.25 1,439,881 1,253,056  
      income before income taxes
             -22,638,000 -72,046,000 44,366,000 -62,872,000 -63,372,000 -29,924,000 -26,818,000 -20,732,000 -48,430,315 -13,611,213 -19,835,570 -2,673,728 11,878,458 20,335,708 23,896,982 12,037,253 -10,758,871 -5,519,741 -6,042,557 -12,086,108 -10,729,486 -19,420,743 -20,815,860 -19,264,414 -22,219,586 -15,936,053 -28,683,993 -22,575,282 -24,740,736 -11,626,451 -13,982,700 -10,685,732                                   
      benefit from income taxes
                                                            742,500                   
      net income
             -22,638,000 -72,046,000 44,366,000 -62,872,000 -63,374,000 -29,924,000 -26,818,000 -20,732,000 -48,432,715 -13,611,213 -19,835,570 -2,673,728 11,704,905 20,335,708 23,896,982 12,037,253 -10,761,271 -5,519,741 -6,042,557 -12,086,108 -10,731,886 -19,420,743 -20,815,860 -19,264,414 -22,221,986 -15,936,053 -28,683,993 -22,575,282 -24,743,136 -11,626,451 -13,982,700 -10,685,732 -22,430,532 -6,177,628 -6,940,019 -4,780,727 -6,177,628  -6,940,019 -4,780,727 -137,143,031 -8,239,061 -5,584,115 -2,686,799 -130,996,821 -2,013,414 2,699,382 -1,231,430 -122,406,813 -683,796 -1,816,429 -88,956,495 -2,528,617 -8,030,468 -7,502,162  -5,694,815 -5,233,774 -36,048,909 -12,477,548 -6,173,809 -3,707,170 -8,779,523 -3,974,148 -3,106,586 -3,136,953 
      yoy
             -64.28% 140.76% -265.43% 203.26% 30.85% 119.85% 35.20% 675.40% -513.78% -166.93% -183.00% -122.21% -208.77% -468.42% -495.48% -199.60% 0.27% -71.58% -70.97% -37.26% -51.71% 21.87% -27.43% -14.67% -10.19% 37.07% 105.14% 111.27% 10.31% 88.20% 101.48% 123.52% 263.09%  0.00% 0.00% -95.50%  24.28% 77.93% 4.69% 309.21% -306.87% 118.19% 7.02% 194.45% -248.61% -98.62% 4740.86% -91.48% -75.79%  -55.60% 53.44% -79.19%  -7.76% 41.18% 310.60% 213.97% 98.73% 18.18%     
      qoq
             -68.58% -262.39% -170.57% -0.79% 111.78% 11.58% 29.36% -57.19% 255.83% -31.38% 641.87% -122.84% -42.44% -14.90% 98.53% -211.86% 94.96% -8.65% -50.00% 12.62% -44.74% -6.70% 8.05% -13.31% 39.44% -44.44% 27.06% -8.76% 112.82% -16.85% 30.85% -52.36% 263.09% -10.99% 45.17% -22.61%   45.17% -96.51% 1564.55% 47.54% 107.84% -97.95% 6406.20% -174.59% -319.21% -98.99% 17801.07% -62.35% -97.96% 3417.99% -68.51% 7.04%   8.81% -85.48% 188.91% 102.10% 66.54% -57.77% 120.92% 27.93% -0.97%  
      net income margin %
    0% 0%   0% 0% 0% 0% 0% -71.70% -222.28% 29.23% -229.13% -165.54% -65.21% -81.73% -97.32% -634.53% -49.72% -84.30% -9.08% 27.04% 47.63% 49.63% 34.73% -95.61% -59.08% -67.24% -276.86% -123.16% -49063.34% -47579.11% -44032.95% -71110.36% -12877.62% -65563.41% -13221.25% -56555.74% -26574.75% -31960.46% -24424.53% -51269.79% -14120.29% -15862.90% -3006.44% -14120.29%  -15862.90% -3006.44% -3398.24% -17194.44% -17869.17% -11214.62% -3544.46%   -24.65% -1592.11% -510.33% -1226.75%        -22888.41% -2004.11% 166995.10% -33422.02% -22380.19% -1614.00% -5402.76% -1242.36% 
      net income per share
             -0.215 -0.68 0.42 -0.6 -0.61 -0.29 -0.26 -0.2 -0.48 -0.13 -0.2 -0.03 0.12 0.21 0.25 0.13 -0.12 -0.07 -0.08 -0.17 -0.15 -0.32 -0.35 -0.32 -0.34 -0.27 -0.51      -0.44 -0.23 -0.41  -0.23                 -0.19 -0.19  -0.15 -0.14 -0.16 -0.34 -0.18 -0.11 -0.26 -0.12 -0.1 -0.11 
      weighted-average shares outstanding - basic
              105,753 105,545 104,534 103,745 104,099 103,867 102,757 100,722,224 101,843,436 101,653,136 97,090,079 93,858,857 94,935,471 94,155,407 91,091,823                                                   
      weighted-average shares outstanding - diluted
              105,753 107,929 104,534 103,745 104,099 103,867 102,757 100,722,224 101,843,436 101,653,136 97,090,079 98,607,815 98,884,744 98,082,644 95,590,183                                                   
      change in value of derivatives
                              63,065 -27,383 1,483,831 -629,151 -113,359 369,935 -23,524 -534,074 -104,713 168,974 2,382,142 422,864 758,469 -2,951,225 -3,519,579 -321,324 200,747 -29,403 44,275 200,747  -29,403 44,275 3,055,065 915,387 -622,145 -66,904 1,651,356 373,734 404,152                    
      weighted-average shares outstanding - basic and diluted
                             83,638,469 74,772,103 74,629,855 71,444,600 73,898,598 59,966,955 59,779,128 59,548,672 61,050,880 59,492,867 55,719,923 54,692,392 57,358,442 51,931,989 44,321,847 37,741,743 46,933,030 26,134,183 16,461,693 14,113,620   16,461,693                            
      salaries and payroll-related costs
                                4,276,105 6,011,689 4,113,262 4,248,693 3,919,886 7,179,815 3,570,531 3,541,652 3,150,617 6,291,209 2,454,449 3,097,902 2,081,791 5,195,213 1,651,729 1,725,176 1,629,423 1,651,729  1,725,176 1,629,423 21,399,459 1,654,915                         
      stock-based compensation
                                2,424,442 2,009,694 2,750,785 2,416,839 2,380,343 4,047,849 2,486,074 2,205,079 2,014,856 3,526,888 2,038,682 1,198,444 521,138 1,937,909 363,593 355,108 395,675 363,593  355,108 395,675 12,744,280 415,920 169,390 251,878 11,261,113 346,707                     
      depreciation and amortization
                                1,185,611 1,154,525 818,200 803,912 794,349 843,584 741,058 449,559 290,039 855,551 276,054 395,779 403,405 270,417 454,086 448,765 449,597 454,086  448,765 449,597                           
      acquired in-process research and development
                                       10,142,786                                        
      gain on sale of fixed assets
                                       45,576 -26,381   -5,316 -53,562  -39,949 -54,932 18,493 -39,949  -54,932 18,493   -33,484                        
      net income attributable to non-controlling interests
                                                                               
      net income attributable to arrowhead
                                     -22,221,986 -15,936,053 -28,683,993 -22,575,282 -24,743,136 -11,628,919 -13,942,521 -10,628,312 -22,430,442 -6,079,010 -6,757,937 -4,614,159 -6,079,010  -6,757,937 -4,614,159 -119,021,473 -7,991,510 -5,335,233 -2,485,505 -113,355,430 -1,819,917 2,905,237 -1,437,682 -106,808,965 -371,055 -1,544,927                
      other comprehensive income, net of tax
                                                                               
      comprehensive loss attributable to arrowhead
                                     -14,848,825.75 -15,938,035 -28,747,958 -22,575,282 -24,813,614 -11,628,919 -13,942,521                                    
      shareholders - basic & diluted:
                                        -0.41 -0.41 -0.22 -0.31 -0.28    -0.33                               
      equity in income of unconsolidated affiliates
                                          78,702 -9,597 -138,456 -9,524 -159,530 -157,612 -63,557 -159,530  -157,612 -63,557 -758,046 -34,573 -64,261 -106,527                       
      net income attributable to noncontrolling interests
                                          -2,468 40,179 57,420   182,082 166,568                               
      impairment expense
                                              1,308,047   1,308,047                              
      income from continuing operations before income taxes
                                             -22,425,232 -6,177,628 -6,939,683 -4,780,709 -6,177,628  -6,939,683 -4,780,709 -94,305,002 -8,239,738 -5,583,632 -2,686,579 -82,865,876 -1,944,672 -1,087,336 -491,883                   
      income from continuing operations
                                             -22,430,532 -6,177,628 -6,939,683 -4,780,709 -6,177,628  -6,939,683 -4,780,709 -94,305,002 -8,239,738 -5,583,632 -2,686,579 -82,865,876 -1,944,672 -1,087,336 -1,234,383 -115,217,816 -678,247 -2,230,662 -82,655,938 -2,528,617 -8,030,468 -7,787,336  -5,694,815 -5,233,774 -34,631,007 -12,477,548 -6,173,809 -3,707,170 -8,779,523 -3,974,148 -3,106,586 -3,136,953 
      income from discontinued operations
                                               -336 -18   -336 -18 -47,546,617 677 -483 -220 -48,920,320 -68,742 -132,495 2,953 -7,187,397 -5,549 -15,767               
      net income from discontinued operations
                                               -336 -18   -336 -18 -42,838,029 677 -483 -220 -48,130,945 -68,742                     
      net (gain) loss attributable to non-controlling interests
                                             90 98,618                                 
      contingent consideration - fair value adjustments
                                                                               
      impairment of investment in unconsolidated affiliates
                                                     -187,000 -1,455,775                         
      gain on purchase of roche madison
                                                        1,576,107                       
      realized and unrealized gain in marketable securities
                                                     -14,522.75   -58,091   359,920                65,252.5 124,549 133,195  
      gain on sale of stock in subsidiary
                                                                               
      gain on disposal of discontinued operations
                                                         789,375  3,919,213                    
      realized and unrealized gain investments
                                                                               
      net (income) loss attributable to noncontrolling interests
                                                 98,618  182,082 166,568 18,121,558 247,551 248,882 201,294 17,641,391 193,497 205,855 -206,252                   
      weighted-average shares outstanding—basic and diluted
                                                 26,134,183   14,113,620    10,121,069    71,779,410  64,579,403                 
      earnings per share - basic and diluted:
                                                                               
      income from continuing operations attributable to arrowhead common shareholders
                                                   -0.41 -0.33 -0.37 -0.71 -0.5 -0.25 -0.018 -0.03  -0.02 -0.018 -0.01 -0.04                
      income from discontinued operations attributable to arrowhead common shareholders
                                                         0.018  0.05  0.003  0.01                
      net income attributable to arrowhead shareholders
                                                   -0.41  -0.37 -0.71 -0.5 -0.25  -0.03 0.04 -0.02 -0.015 -0.01 -0.03                
      notes payable
                                                                               
      earnings per share—basic and diluted:
                                                                               
      notes payable, net of current portion
                                                    -0.33                           
      depreciation & amortization
                                                     325,451.5 423,414 423,948                        
      gain on sale of property and equipment
                                                     -227,440.25 -876,277                         
      earnings per share - basic:
                                                                               
      weighted-average shares outstanding
                                                      11,238,291 10,663,869   71,826,276 7,180,669,478,913,948                    
      earnings per share - diluted:
                                                                               
      salaries and payroll related costs
                                                       2,017,064                        
      earnings per share—basic:
                                                                               
      earnings per share—diluted:
                                                                               
      salaries
                                                        1,320,693 18,889,495 354,223 787,696 1,056,437 41,268,908 914,336 1,104,103 33,739,318 889,428 3,134,826 3,896,950  3,343,701 2,911,290 13,839,676 2,800,420 2,014,740 1,726,548 1,604,726 2,036,639 1,463,539 1,366,266 
      amortization of intangible assets
                                                        71,618                       
      patent amortization
                                                         1,600,588 60,452 60,452 78,906 1,865,372 78,906 78,906 1,478,277 100,103 89,530 102,602  103,991 103,991         
      loss on equity of investments - nanotope
                                                         -626,886 -70,366                     
      loss on sale of fixed assets
                                                                -51,802 -78,029              
      realized and unrealized gain on marketable securities
                                                         259,531 -498,406                     
      gain on equity of investments - nanotope
                                                           -74,827                    
      consulting
                                                            230,528 7,959,193 207,746 101,239 6,706,545 406,212 598,757 902,031  687,166 583,032 2,389,209 637,052 389,638 231,406 309,993 171,375 149,874 118,478 
      gain on equity of investments—nanotope
                                                            48,826                   
      gain on sale of equity of investments—ensysce
                                                                               
      change in value of derivative liability
                                                            465,270 209,157 1,552,228                 
      gain from discontinued operations
                                                            2,953       285,174            
      loss on equity of investments—nanotope
                                                             -41,431.75 -66,489 -48,639                
      gain/(loss) on sale of fixed assets
                                                             -129,493 13,000                 
      gain/(loss) from discontinued operations
                                                             -7,546,772 -5,549                 
      gain/(loss) on disposal of discontinued operations
                                                             359,375                  
      less: net income attributable to noncontrolling interests
                                                             15,597,848 312,741 271,502                
      gain/loss on disposal of discontinued operations
                                                               430,000                
      earnings per share-basic and diluted:
                                                                               
      weighted-average shares outstanding, basic and diluted
                                                               58,649,086      38,754,239   36,422,464 34,232,149 34,181,399 31,953,806   27,987,281 
      revenue, note 1
                                                                892,641 2,633,191 701,723 235,372  729,766 402,861         
      loss on equity of invesment—nanotope
                                                                -44,428.5 -48,302              
      gain on sale of equity of investment—ensysce
                                                                175,000  700,000             
      income before minority interests
                                                                -97,943,616 -2,528,617 -8,030,528 -9,781,424  -6,839,810 -6,569,750 -40,404,040 -13,159,015 -8,108,440      
      minority interests
                                                                15,287,678  60 1,994,088  1,144,995 1,335,976 5,773,033 681,467 1,934,631 453,253 -285,644 221,298 584,499 796,437 
      income from operation of discontinued—nanotechnica, inc.
                                                                               
      loss on disposal of nanotechnica, inc.
                                                                               
      income from operation of discontinued—aonex technologies, inc.
                                                                               
      gain on sale of aonex technologies, inc.
                                                                   306,344            
      loss per share from continuing operations, diluted and undiluted
                                                                -0.093 -0.06              
      loss per share, diluted and undiluted
                                                                -0.093 -0.06              
      weighted-average shares outstanding, diluted and undiluted
                                                                 43,353,848 42,934,517    38,626,023         
      loss on equity of investment—nanotope
                                                                  -69,382             
      income from continuing operations per share, diluted and undiluted
                                                                  -0.19    -0.14         
      cost of goods sold
                                                                   160,742  394,817 327,206         
      gross profit on sales
                                                                   74,630  334,949 75,655 1,583,988 274,998       
      income from discontinued operations—nanotechnica, inc.
                                                                               
      income from discontinued operations—aonex technologies, inc.
                                                                   -21,170            
      income from continuing operations per share, basic & diluted
                                                                   -0.2            
      income from discontinued operations per share, basic & diluted
                                                                   0.01            
      weighted-average shares outstanding, basic & diluted
                                                                   38,891,995            
      income from operation of discontinued nanotechnica, inc.
                                                                               
      income from continuing operations per share, basic and diluted
                                                                     -0.15  -0.16 -0.34 -0.18 -0.11    -0.11 
      cost of good sold
                                                                       86,900.25 347,601       
      patents amortization
                                                                       77,993.25 103,991 103,991      
      goodwill impairment & other charges
                                                                               
      general & administrative expenses
                                                                          1,176,929    1,098,095 
      research & development
                                                                          1,349,849    1,722,393 
      realized & unrealized gain in marketable securities
                                                                              3,266 
      patents - amortization
                                                                           -45,330 -60,440  -60,440 
      income from continuing operations per share, undiluted
                                                                           -0.083 -0.12 -0.1  
      weighted-average shares outstanding, undiluted
                                                                            33,810,131 32,151,954  
      patents—amortization
                                                                             -60,440  
      income from continuing operations per share, fully diluted
                                                                             -0.1  
      weighted-average shares outstanding, fully diluted
                                                                             32,151,954  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.